ALMR
Alamar Biosciences, Inc.
32.50$
-4.7%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Cash Flow
Alamar Biosciences, Inc. (ALMR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -11 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 25 | Q2 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|
| -13 | -12 | -20 | -11 | |
| 0.9 | 0.9 | 1.2 | 1.1 | |
| 0.6 | 0.7 | 1.5 | 4.7 | |
| -7.1 | -6.5 | -11 | -4.8 | |
| 1.0 | 1.1 | 0.6 | 3.6 | |
| – | – | -0.8 | -121 | |
| 0.0 | 0.0 | 57 | 0.0 | |
| 0.2 | 0.2 | 56 | 202 | |
| 4.3 | 6.6 | 65 | 68 | |
| -14 | -13 | -21 | -15 |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.